Actinium Pharmaceuticals, Inc. (ATNM)
R&D Expense Growth
27.99%
Quarterly · Period ending:
ATNM R&D Expense Growth
Latest reported27.99%period ending
Latest reported27.99%period ending
ATNM Quarterly R&D Growth (QoQ) (0.00% → 27.99%)
Latest values, visible window
High-resolution chart · PNG
ATNM r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 27.9933% | |
| -14.4748% | |
| 15.6309% | |
| -12.933% | |
| -36.6364% | |
| 67.137% | |
| -51.87% | |
| 10.8384% | |
| 34.5381% | |
| -18.9418% | |
| -30.6689% | |
| 5.0589% | |
| 38.5145% | |
| 9.4395% | |
| 9.4962% | |
| 46.1401% | |
| 5.9074% | |
| -19.8333% | |
| 12.1283% | |
| 29.6613% | |
| -15.0842% | |
| -7.825% | |
| 22.4657% | |
| 7.9818% | |
| -15.4902% | |
| 23.0414% | |
| -30.152% | |
| 20.4489% | |
| -7.5185% | |
| -14.7296% | |
| 20.4691% | |
| 26.9474% | |
| -25.4985% | |
| 21.5414% | |
| -25.9229% | |
| 13.1994% | |
| -2.7753% | |
| 15.428% | |
| -31.3753% | |
| 37.0781% | |
| 10.1726% | |
| 44.975% | |
| -8.1683% | |
| -26.3158% | |
| -5.2112% | |
| 0.4465% | |
| 6.8381% | |
| 88.4615% | |
| -18.651% | |
| 738.0469% | |
| -62.2659% | |
| 52.8156% | |
| -53.1066% | |
| -6.5404% | |
| -30.7096% | |
| 178.9087% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |